{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:23:52Z","timestamp":1764937432659,"version":"3.40.5"},"reference-count":13,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n<jats:title>Purpose:<\/jats:title>\n<jats:p>The simultaneous occurrence of cerebral toxoplasmosis and cryptococcosis is\nrare. The infections continue to be treated with sulfadiazine and amphotericin-B-based regimens\n(preferred therapy), respectively. Both these drugs are linked to some serious adverse drug reactions\n(ADRs). We report such a unique instance of both; the CNS co-infections and adverse drug\nreactions to the preferred therapy.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case Presentation:<\/jats:title>\n<jats:p>A 44-year-old Asian-Indian female was diagnosed with cerebral toxoplasmosis,\nimpending cryptococcal meningoencephalitis, and acquired immune deficiency syndrome\n(AIDS). The preferred therapy of opportunistic CNS co-infections commenced. Within a week, she\nhad an occurrence of fall in hemoglobin concentrations (11.3 g\/dL to 5.6 g\/dL; grade IV), reticulocytosis\n(1% to 3.2%), and indirect hyperbilirubinemia (0.5 mg\/dL to 2.8 mg\/dL; grade IV) after\nsulfadiazine administration. The drug was discontinued and the patient was treated with hematocrit\ntransfusions. After amphotericin-B deoxycholate (AmBd) administration, the patient developed\nhypokalemia (serum potassium; 4.5 mmol\/L to 2.7 mmol\/L) and increased serum creatinine (1.0 to\n2.2 mg\/dL; stage-I) levels. Hence, AmBd was discontinued and potassium correction was given.\nThe patient got diagnosed with sulfadiazine induced hemolytic anemia and AmBd induced acute\nrenal failure. He was switched to alternative therapy regimens for the treatment of cerebral toxoplasmosis\nand cryptococcosis. Radiological investigations were followed up to confirm the clinical\noutcomes of alternative therapy. Complete recovery from the ADRs and opportunistic infections\nwas observed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The preferred therapy regimens for toxoplasmosis and cryptococcosis are accompanied\nby potential adverse drug reactions, thus continuous monitoring is vital, especially in\nthe initial phases of therapy. Discontinuation of the treatment should be the preliminary intervention\nin the management. Having said that, alternative therapy regimens had an optimal clinical response\nin the present case.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574886317666220707144418","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T11:59:25Z","timestamp":1657195165000},"page":"393-397","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Case of Cerebral Toxoplasmosis and Cryptococcosis Preferred Therapy\nAssociated Adverse Drug Reactions in a Patient Newly Co-diagnosed with\nAcquired Immune Deficiency Syndrome"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8334-4025","authenticated-orcid":true,"given":"Vaibhav Rajendra","family":"Suryawanshi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Pune,\n411038, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharat","family":"Purandare","sequence":"additional","affiliation":[{"name":"Fellowship in Infectious Diseases, Consultant Physician, Bharati Hospital and Research\nCentre, Pune, 411046, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujata","family":"Rege","sequence":"additional","affiliation":[{"name":"Fellowship in Infectious Diseases, Consultant Physician, Bharati Hospital and Research\nCentre, Pune, 411046, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8807-196X","authenticated-orcid":true,"given":"Bijoy Kumar","family":"Panda","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Pune,\n411038, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4103\/2348-3334.158703","volume":"2","author":"Koshy J.M.","year":"2015","unstructured":"Koshy J.M.; Deodhar D.; Brar I.; Central nervous system manifestations in human immunodeficiency virus patients in the antiretroviral therapy era-Scenario from a developing country. CHRISMED J Health Res 2015,2(3),245-250","journal-title":"CHRISMED J Health Res"},{"key":"ref=2","unstructured":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. 2018. Available from:"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1179\/joc.2000.12.6.463","volume":"12","author":"Fanos V.","year":"2000","unstructured":"Fanos V.; Cataldi L.; Amphotericin B-induced nephrotoxicity: A review. J Chemother 2000,12(6),463-470","journal-title":"J Chemother"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"7224","DOI":"10.1128\/AAC.01698-15","volume":"59","author":"Bicanic T.","year":"2015","unstructured":"Bicanic T.; Bottomley C.; Loyse A.; Toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis. Antimicrob Agents Chemother 2015,59(12),7224-7231","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1136\/jnnp.49.3.328","volume":"49","author":"Bahls F.","year":"1986","unstructured":"Bahls F.; Sumi S.M.; Cryptococcal meningitis and cerebral toxoplasmosis in a patient with acquired immune deficiency syndrome. J Neurol Neurosurg Psychiatry 1986,49(3),328-330","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref=6","first-page":"660","volume":"36","author":"Murray-Pulsifer K.","year":"1993","unstructured":"Murray-Pulsifer K.; Two central nervous system infectious diseases in a patient with AIDS. J Fam Pract 1993,36(6),660-664","journal-title":"J Fam Pract"},{"key":"ref=7","first-page":"107","volume":"2","author":"Murty O.P.","year":"2007","unstructured":"Murty O.P.; Cerebral toxoplasmosis and cryptococcus meningitis with genital candidiasis: Proven only after autopsy. Mal J For Path Sci 2007,2,107-117","journal-title":"Mal J For Path Sci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1080\/17843286.2018.1457761","volume":"73","author":"Gonzales Zamora J.A.","year":"2018","unstructured":"Gonzales Zamora J.A.; Dual infection of the central nervous system caused by cryptococcus and toxoplasma in a patient with AIDS: A case report and literature review. Acta Clin Belg 2018,73(6),448-452","journal-title":"Acta Clin Belg"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2165\/11536520-000000000-00000","volume":"33","author":"Youngster I.","year":"2010","unstructured":"Youngster I.; Arcavi L.; Schechmaster R.; Medications and glucose-6-phosphate dehydrogenase deficiency: An evidence-based review. Drug Saf 2010,33(9),713-726","journal-title":"Drug Saf"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"7e12","DOI":"10.1309\/AJCPBVLJZH6W6RQM","volume":"136","author":"Pierce A","year":"2011","unstructured":"Pierce A; Nester T;  Pathology consultation on drug-induced hemolytic anemia Am J Clin Pathol 2011,136(1),7e12","journal-title":"Pathology consultation on drug-induced hemolytic anemia Am J Clin Pathol"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010481.pub2","author":"Botero Aguirre J.P.","year":"2015","unstructured":"Botero Aguirre J.P.; Restrepo Hamid A.M.; Amphotericin B deoxycholate versus liposomal amphotericin B: Effects on kidney function. Cochrane Database Syst Rev 2015(11)","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4103\/0972-5229.35083","volume":"11","author":"Rajeshwari S.S.","year":"2007","unstructured":"Rajeshwari S.S.; Adhikari P.; Ramapuram J.T.; Amphotericin B for cryptococcal meningitis in HIV positive patients: Low dose versus high dose. Indian J Crit Care Med 2007,11,112-116","journal-title":"Indian J Crit Care Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"Naranjo C.A.","year":"1981","unstructured":"Naranjo C.A.; Busto U.; Sellers E.M.; A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981,30(2),239-245","journal-title":"Clin Pharmacol Ther"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886317666220707144418","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/206718\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886317666220707144418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T15:06:57Z","timestamp":1691334417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/206718\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886317666220707144418","relation":{},"ISSN":["1574-8863"],"issn-type":[{"type":"print","value":"1574-8863"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-02-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}